| Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research H Al-Lawati, Z Binkhathlan, A Lavasanifar European Journal of Pharmaceutics and Biopharmaceutics 142, 179-194, 2019 | 47 | 2019 |
| Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research H Al-Lawati, HM Aliabadi, BS Makhmalzadeh, A Lavasanifar Expert opinion on drug delivery 15 (4), 397-418, 2018 | 37 | 2018 |
| Reduced heart exposure of diclofenac by its polymeric micellar formulation normalizes CYP-mediated metabolism of arachidonic acid imbalance in an adjuvant arthritis rat model … H Al-Lawati, MR Vakili, A Lavasanifar, S Ahmed, F Jamali Molecular pharmaceutics 17 (4), 1377-1386, 2020 | 18 | 2020 |
| Onset of action and efficacy of ibuprofen liquigel as compared to solid tablets: A systematic review and meta-analysis H Al Lawati, F Jamali Journal of Pharmacy & Pharmaceutical Sciences 19 (3), 301-311, 2016 | 13 | 2016 |
| Dose-dependency of the cardiovascular risks of non-steroidal anti-inflammatory drugs SA Ahmed, H Al-Lawati, F Jamali Inflammopharmacology 27 (5), 903-910, 2019 | 12 | 2019 |
| Delivery and biodistribution of traceable polymeric micellar diclofenac in the rat H Al-Lawati, MR Vakili, A Lavasanifar, S Ahmed, F Jamali Journal of Pharmaceutical Sciences 108 (8), 2698-2707, 2019 | 12 | 2019 |
| Relocating Glyceryl Trinitrate as an Anti-Virulence Agent against Pseudomonas aeruginosa and Serratia marcescens: Insights from Molecular and In Vivo … SI Nazeih, MAM Ali, ASA Halim, H Al-Lawati, HA Abbas, M Al-Zharani, ... Microorganisms 11 (10), 2420, 2023 | 11 | 2023 |
| Pharmacokinetic and tissue distribution of orally administered cyclosporine A-loaded poly (ethylene oxide)-block-Poly (ε-caprolactone) micelles versus Sandimmune® in rats Z Binkhathlan, R Ali, W Qamar, H Al-Lawati, A Lavasanifar Pharmaceutical Research 38, 51-65, 2021 | 7 | 2021 |
| Polymeric micelles for the delivery of diclofenac and its ethyl ester derivative H Al-Lawati, M R Vakili, F Jamali, A Lavasanifar Pharmaceutical Nanotechnology 4 (2), 109-119, 2016 | 4 | 2016 |
| Alendronate for Effective Treatment of Male Osteoporosis: An Insight H Al Lawati, S Al Busaidi, T Al Rawahi, A Al Lawati, A Kifah, S Das Current Pharmaceutical Design 31 (1), 26-36, 2025 | | 2025 |
| Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus A Al-Busaidi, O Alabri, J Alomairi, A ElSharaawy, A Al Lawati, H Al Lawati, ... Current Diabetes Reviews 21 (1), E170124225723, 2025 | | 2025 |
| Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Non-Melanoma Skin Cancer H Al Lawati SKIN The Journal of Cutaneous Medicine 7 (5), 976-981, 2023 | | 2023 |
| A Review of the Pharmacokinetics of Cyclosporin H Al Lawati IJFMR-International Journal For Multidisciplinary Research 4 (6), 2022 | | 2022 |
| Development of Polymeric Micelles for Site Specific Delivery of Nonsteroidal Anti-Inflammatory Drugs: Effect on the Cardiovascular Risk in an Experimental Model of Arthritis HM Al Lawati | | 2019 |
| Design and evaluation of a structured assessment of pharmaceutical care issues H Al-Lawati, L Perry, J Johnson, SA Hudson Pharmacy World and Science 31 (1), 53-53, 2009 | | 2009 |
